[Treatment of cerebral infarction patients with IGT].
Fushimi
Hisako
H
Sumitomo Hospital.
D000928:Antidepressive Agents / Q000627:therapeutic use; D000983:Antipyrine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069059:Atorvastatin; D002544:Cerebral Infarction / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control / Q000628:therapy*; D000077553:Edaravone; D016166:Free Radical Scavengers / Q000627:therapeutic use; D018149:Glucose Intolerance / Q000150:complications* / Q000503:physiopathology; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000628:therapy; D006973:Hypertension / Q000150:complications / Q000628:therapy; D015228:Hypertriglyceridemia / Q000150:complications / Q000628:therapy; D007333:Insulin Resistance; D011758:Pyrroles / Q000627:therapeutic use; D055502:Secondary Prevention; D015912:Thrombolytic Therapy
D000928:Antidepressive Agents; D016166:Free Radical Scavengers; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin; D000077553:Edaravone; D000983:Antipyrine